MODALITY PARTNERSHIP (AWC)
LONG LEE SURGERY, LONG LEE LANE, LONG LEE, KEIGHLEY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 4 | 6 | 66.7% | |
| HF 4 | 2011 | 10 | 13 | 76.9% | |
| HF 4 | 2012 | 15 | 15 | 100.0% | |
| HF 4 | 2013 | 19 | 19 | 100.0% | |
| HF004 | 2014 | 13 | 14 | 92.9% | |
| HF004 | 2015 | 17 | 18 | 94.4% | |
| HF004 | 2016 | 13 | 13 | 100.0% | |
| HF004 | 2017 | 14 | 16 | 87.5% | |
| HF004 | 2018 | 17 | 17 | 100.0% | |
| HF004 | 2019 | 18 | 19 | 94.7% | |
| HF004 | 2020 | 21 | 25 | 84.0% | |
| HF006 | 2021 | 27 | 32 | 84.4% | |
| HF006 | 2022 | 350 | 373 | 93.8% | |
| HF006 | 2023 | 366 | 391 | 93.6% |
